Clinical trial No longer in our active list Observational Ages 18 to 75

Assessing hand dexterity in patients with cervical myelopathy

Official title: Establishing the Validity and Reliability of a Dexterity Assessment Tool in DCM and Healthy Populations

Run by Western University, Canada · NCT05910593 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new tool to see if it can accurately measure hand function in people with cervical myelopathy to help track their condition better.

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment102 (estimated)
SponsorWestern University, Canada
Academic / other
Locations1 site (London, Ontario)
Trial IDNCT05910593 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 35 to 75 who have been diagnosed with degenerative cervical myelopathy and have no other neurological disorders.

Probably not a fit

Patients who do not speak and read English fluently will not benefit from this study due to the language requirements for participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate a newly developed portable dexterity assessment tool designed to measure hand function in patients diagnosed with degenerative cervical myelopathy (DCM). The tool seeks to identify subtle changes in dexterity that may correlate with the severity of myelopathy, potentially allowing for earlier diagnosis and treatment. By establishing the validity and reliability of this assessment tool, the study hopes to enhance the monitoring of disease progression and recovery. Participants will include both individuals diagnosed with DCM and healthy controls, aged 35 to 75, who meet specific eligibility criteria.

Why it matters

Potential benefit: If successful, this study could lead to improved early diagnosis and treatment of degenerative cervical myelopathy, ultimately preserving hand function in affected patients.

How similar studies have gone: While this approach is innovative in its focus on subtle changes in dexterity, similar studies have shown promise in using assessment tools to monitor neurological conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria for patient participants

* Has been diagnosed with DCM
* Are between the ages of 35 and 75 years
* Has no other neurological disorder Inclusion criteria for healthy participants
* Are between the ages of 35 and 75 years
* Has no neurological disorder

Exclusion criteria for all participants:

• Does not fluently speak and read English

Where it's running

  • LHSC - University Hospital
    London, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.